Installing a Ketocarotenoid Branch in Phaeodactylum tricornutum via Functional Activation of Chlamydomonas reinhardtii β-Carotene Ketolase
Marine Drugs · 2025
DOI: 10.3390/md23120470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Hengshen Chao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Technology Research Center for Marine Algal Bioengineering, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518055…. Hauptthemen laut MEDLINE: Chlamydomonas reinhardtii, Diatoms, Oxygenases. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National key research and development plan special project for synthetic biology, The Shenzhen Scientific Project, Guangdong Natural Science Foundation.
Abstract (Originalsprache)
Astaxanthin is a high-value ketocarotenoid antioxidant, but its industrial production from Haematococcus pluvialis is constrained by multi-stage cultivation and a rigid cell wall that hinders downstream extraction. The marine diatom Phaeodactylum tricornutum, which lacks these limitations, represents a promising alternative chassis because it grows fast, lacks a recalcitrant wall, and supports efficient pigment accumulation. This study establishes a functional ketocarotenoid biosynthetic branch in P. tricornutum through rational metabolic engineering. To address challenges in protein targeting posed by the host’s complex plastid architecture, we performed heterologous expression of the Chlamydomonas reinhardtii β-carotene ketolase (CrBKT), fused at its N-terminus to bipartite transit peptides derived from two endogenous proteins. Western blotting and UPLC-MS/MS analysis confirmed that only the transit peptide fused constructs produced stable protein and functional activity, whereas the native CrBKT failed. The rationally engineered strain successfully accumulated ~45 µg/g DCW of canthaxanthin and ~15 µg/g DCW of astaxanthin. Metabolomic profiling revealed a 50% reduction in fucoxanthin, indicating a substantial redirection of metabolic flux from the native pathway toward the engineered ketocarotenoid branch. This work establishes P. tricornutum as a viable platform for ketocarotenoid production and highlights the critical role of evolution-aware plastid targeting in heterologous pathway reconstruction within complex algal systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Technology Research Center for Marine Algal Bioengineering, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518055, China.
- Shenzhen Engineering Laboratory for Marine Algal Biological Development and Application, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China.
- College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China.
- Instrumental Analysis Center of Shenzhen University, Shenzhen 518060, China.
ORCID-Profile: Hengshen Chao, Rasool Kamal, Chaogang Wang
Förderung
- National key research and development plan special project for synthetic biology
- The Shenzhen Scientific Project
- Guangdong Natural Science Foundation
- Shenzhen Scientific Project
Zitieren
APA
Chao, H., Kamal, R., Wu, Y., Huang, D., & Wang, C. (2025). Installing a Ketocarotenoid Branch in Phaeodactylum tricornutum via Functional Activation of Chlamydomonas reinhardtii β-Carotene Ketolase. Marine Drugs. https://doi.org/10.3390/md23120470
Vancouver
Chao H, Kamal R, Wu Y, Huang D, Wang C. Installing a Ketocarotenoid Branch in Phaeodactylum tricornutum via Functional Activation of Chlamydomonas reinhardtii β-Carotene Ketolase. Marine Drugs. 2025. doi:10.3390/md23120470
BibTeX
@article{Chao2025,
author = {Chao, Hengshen and Kamal, Rasool and Wu, Yan and Huang, Danqiong and Wang, Chaogang},
title = {Installing a Ketocarotenoid Branch in Phaeodactylum tricornutum via Functional Activation of Chlamydomonas reinhardtii β-Carotene Ketolase},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23120470}
}
EUVIMED